SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,515,000 | -40.4% | 109,000 | -31.3% | 0.24% | -17.2% |
| Q4 2021 | $14,282,000 | +385.6% | 158,600 | +398.7% | 0.29% | +225.8% |
| Q3 2021 | $2,941,000 | +26.1% | 31,800 | +6.0% | 0.09% | +7.2% |
| Q2 2021 | $2,332,000 | -8.0% | 30,000 | -11.8% | 0.08% | +31.7% |
| Q1 2021 | $2,534,000 | -70.9% | 34,000 | -33.5% | 0.06% | -62.0% |
| Q4 2020 | $8,712,000 | +41.0% | 51,100 | +16.1% | 0.17% | -27.5% |
| Q3 2020 | $6,180,000 | +492.5% | 44,000 | +576.9% | 0.23% | +218.1% |
| Q2 2020 | $1,043,000 | -36.3% | 6,500 | -56.7% | 0.07% | -83.0% |
| Q4 2018 | $1,637,000 | +929.6% | 15,000 | +328.6% | 0.42% | +1043.2% |
| Q3 2017 | $159,000 | – | 3,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |